BeStock  

IDEXX Laboratories Inc IDXX

US equityMarket cap rank #396Diagnostics & Research
$676.21 −$13.44 (-1.95%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $674.72 -0.22%
Open$688.61
Prev close$689.65
Day range$672.72 – $696.89
Volume614.4K
Market cap$53.28B
P/E (TTM)45.6
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership95.8%-0.07 pts vs. prior quarter
Institutions holding1,622-8 vs. prior quarter
Insider trades (recent)35 buys / 15 sellsNet buying
Short interest2.99% of floatDays to cover 4.5 · as of 30 Oct 2026
Short-sale volume share14.4%5-day average of daily volume

Short-sale volume as % of daily volume

7%11%14%18%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$9.30M (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

+$3.4MSuper+$5.9MBig+$5.6MMid+$36.6MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 31.0% of shares outstanding.

Largest holders

  • BlackRock10.28%
  • Vanguard Capital Management, LLC7.12%
  • Vanguard Portfolio Management, LLC5.02%
  • State Street Global Advisors4.77%
  • Invesco Capital Management LLC3.77%
  • Geode Capital Management, LLC3.33%
  • Baron Capital Group, Inc.2.26%
  • UBS Asset Management1.89%

By investor type

  • Mutual Fund81.79%
  • Hedge Fund4.11%
  • Public Company3.50%
  • Government Pension Fund2.88%
  • Private Company1.53%
  • Family Office/Trust0.55%
  • Sovereign Wealth Fund0.54%
  • Insurance Company0.42%

Reported short interest has risen from 2.46% to 2.99% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
T. Rowe Price Group, Inc. Mutual Fund 2026/Q4 +915,772 1.7%
Goldman Sachs Asset Management, L.P. Mutual Fund 2026/Q4 +498,245 1.4%
Millennium Management LLC Hedge Fund 2026/Q4 +326,655 0.6%
Arrowstreet Capital, Limited Partnership Mutual Fund 2026/Q4 +292,353 1.7%
UBS Asset Management Mutual Fund 2026/Q4 +214,661 1.9%
Jupiter Fund Management Plc Mutual Fund 2026/Q4 +214,081 0.4%
Schroder Investment Management Limited Mutual Fund 2026/Q4 +172,689 0.5%
Holocene Advisors, LP Hedge Fund 2026/Q4 +158,297 0.4%
Los Angeles Capital Management LLC Mutual Fund 2026/Q4 +132,860 0.2%
FMR Mutual Fund 2026/Q4 +116,793 0.9%
Merrill Lynch, Pierce, Fenner & Smith Incorporated Private Company 2026/Q4 +89,504 0.2%
Morgan Stanley Public Company 2026/Q4 +84,681 0.7%
Artisan Partners Limited Partnership Mutual Fund 2026/Q4 +80,073 0.1%
RBC Global Asset Management Inc. Mutual Fund 2026/Q4 +78,968 0.2%
ING Groep N.V. Public Company 2026/Q4 +73,685 0.1%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
9 Nov 2026 George Fennell Executive Vice President of Global CAG Commercial Derivative Exercise and Retained +1,749 $206.94 12,182
3 Nov 2026 Daniel Junius Independent Director Open Market Disposition -1,200 $705.78 2,361
3 Nov 2026 Daniel Junius Independent Director Intent to Sell (Form 144) -1,200 $705.78 –
3 Nov 2026 Sharon Underberg Executive VP, General Counsel, & Corporate Secretary Derivative Exercise and Sale -8,906 $690.02 7,169
3 Nov 2026 Jonathan Mazelsky Executive Chairperson Derivative Exercise and Sale -25,140 $711.95 83,803
3 Nov 2026 Michael Lane Executive VP and GM Global Reference Laboratories, Diagnostic Solutions & Information Technology Open Market Disposition -3,978 $689.70 4,301
29 Oct 2026 Joseph Hooley Independent Director Other Acquisition +48 $551.21 215
3 Sep 2026 Lawrence Kingsley Lead Independent Director Derivative Exercise and Sale -2,203 $532.08 8,570
19 Aug 2026 Andrew Emerson Chief Financial Officer Derivative Exercise and Sale -86 $178.26 4,356
19 Aug 2026 Andrew Emerson Chief Financial Officer Derivative Exercise and Retained +179 $178.26 4,356
29 Jul 2026 Joseph Hooley Independent Director Other Acquisition +49 $558.80 158
31 May 2026 George Fennell Executive Vice President of Global CAG Commercial Derivative Exercise and Sale -284 $566.79 10,433
31 May 2026 George Fennell Executive Vice President of Global CAG Commercial Derivative Exercise and Retained +355 – 10,433
11 May 2026 Daniel Junius Independent Director Other Derivative Acquisition +234 – 234
11 May 2026 Daniel Junius Independent Director Other Derivative Acquisition +525 $533.92 525
11 May 2026 Bruce Claflin Independent Director Other Derivative Acquisition +234 – 1,354
11 May 2026 Bruce Claflin Independent Director Other Derivative Acquisition +525 $533.92 525
11 May 2026 Stuart Essig Independent Director Other Derivative Acquisition +234 – 234
11 May 2026 Stuart Essig Independent Director Other Derivative Acquisition +525 $533.92 525
11 May 2026 Joseph Hooley Independent Director Other Derivative Acquisition +234 – 234

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 2,354,117 3.0% 4.5
15 Oct 2026 1,929,268 2.4% 3.6
30 Sep 2026 1,940,639 2.5% 3.9
15 Sep 2026 1,917,016 2.4% 3.8
31 Aug 2026 2,092,080 2.7% 4.4
14 Aug 2026 1,937,469 2.5% 2.6

Discussion

No comments yet — be the first to weigh in on IDXX.

Sign in to join the discussion.

Scroll to Top